+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years - 70Years
All Genders
ID03476538

Study of How Bariatric Surgery Affects Gabapentin Levels in the Body

Led by Norwegian University of Science and Technology · Updated on 2026-07-08

12

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating the effects of bariatric surgery, including gastric bypass and sleeve gastrectomy, on how the body processes the medication gabapentin. The study aims to understand changes in drug absorption and metabolism caused by alterations in gastric pH, emptying time, gastrointestinal transit, and enzyme activity after surgery. Participants who are preparing for gastric bypass or sleeve gastrectomy will be tested while taking their usual gabapentin medication. The study observes how the surgery affects the blood levels of gabapentin over time, focusing on measurements from before surgery up to one year after the procedure. During the study, participants will have their gabapentin concentration measured in blood serum at baseline and at intervals up to one year post-surgery. The research team will monitor these changes to understand the pharmacokinetics of gabapentin after bariatric surgery. Participation involves follow-up visits for sample collection and assessments related to medication metabolism.

CONDITIONS

Brief Title

Bariatric Surgery and Pharmacokinetics of Gabapentin

Research Team

M

Magnus Strømmen, MSc

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here